Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

Updated October 14th, 2020

Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation.

NOW
PLAYING
Magic Mushrooms Go Mainstream: Can They Really Help Alleviate Pain That Sometimes Comes With Cancer?
NOW
PLAYING
A Good Reason to De-Stress This Holiday Weekend: It Could Stave Off Cancer-Causing Conditions
NOW
PLAYING
Help Support the Amazing 10-Year-Old With a Rare Cancer Who Sold Her Art to Help With Her Medical Bills
NOW
PLAYING
Would You Buy These Potato Chips Instead of Another Snack Because They’re Pink? The Breast Cancer "Pinkwashing" Effect, Explained
NOW
PLAYING
Creativity & Help From Her Baby Girl Helped This Mom Stay 'Rock Solid' During Second Cancer, Leukemia
NOW
PLAYING
Cancer After 57 Days at Ground Zero: A Retired Firefighter Shares His 9/11 Story

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.